Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 9 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 96% | 959.01 | 235 / 245 | 91% | 9.05 | 459 / 502 |
stomach | 99% | 711.27 | 357 / 359 | 83% | 12.06 | 236 / 286 |
lung | 100% | 615.91 | 576 / 578 | 76% | 7.08 | 880 / 1155 |
kidney | 93% | 308.66 | 83 / 89 | 80% | 8.53 | 720 / 901 |
ovary | 87% | 758.68 | 157 / 180 | 79% | 10.56 | 340 / 430 |
breast | 94% | 384.12 | 430 / 459 | 69% | 6.70 | 775 / 1118 |
intestine | 75% | 490.31 | 724 / 966 | 83% | 11.04 | 440 / 527 |
uterus | 99% | 953.50 | 169 / 170 | 54% | 4.26 | 247 / 459 |
esophagus | 66% | 221.27 | 951 / 1445 | 63% | 7.96 | 115 / 183 |
thymus | 85% | 194.02 | 555 / 653 | 39% | 2.45 | 238 / 605 |
bladder | 67% | 247.05 | 14 / 21 | 56% | 4.14 | 283 / 504 |
spleen | 100% | 1269.14 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 614.58 | 1199 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 8% | 13.80 | 25 / 328 | 89% | 12.42 | 158 / 178 |
skin | 60% | 1030.28 | 1094 / 1809 | 32% | 1.51 | 150 / 472 |
lymph node | 0% | 0 | 0 / 0 | 90% | 8.51 | 26 / 29 |
peripheral blood | 86% | 1681.67 | 796 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 29% | 44.09 | 76 / 258 | 50% | 8.76 | 116 / 230 |
tonsil | 0% | 0 | 0 / 0 | 40% | 1.22 | 18 / 45 |
blood vessel | 34% | 85.40 | 457 / 1335 | 0% | 0 | 0 / 0 |
liver | 19% | 32.36 | 42 / 226 | 16% | 0.69 | 63 / 406 |
heart | 17% | 33.54 | 145 / 861 | 0% | 0 | 0 / 0 |
brain | 1% | 1.53 | 26 / 2642 | 4% | 0.39 | 29 / 705 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
muscle | 1% | 1.14 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009624 | Biological process | response to nematode |
GO_0071380 | Biological process | cellular response to prostaglandin E stimulus |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0006954 | Biological process | inflammatory response |
GO_0032570 | Biological process | response to progesterone |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0004957 | Molecular function | prostaglandin E receptor activity |
Gene name | PTGER2 |
Protein name | Prostaglandin E receptor 2 Prostaglandin E2 receptor EP2 subtype (PGE receptor EP2 subtype) (PGE2 receptor EP2 subtype) (Prostanoid EP2 receptor) |
Synonyms | |
Description | FUNCTION: Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. The subsequent raise in intracellular cAMP is responsible for the relaxing effect of this receptor on smooth muscle. |
Accessions | ENST00000557436.1 ENST00000245457.6 P43116 G3V2Y6 |